5 Stocks to Invest in According to Billionaire Paul Tudor Jones

1. Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN)

Tudor Investment Corp’s Stake Value: $166,782,000
Percent of Tudor Investment Corp’s 13F Portfolio: 3.15%
Number of Hedge Fund Holders: 69

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) is an American pharmaceutical company that focuses on patients affected by rare diseases. On July 6, AstraZeneca PLC (NASDAQ: AZN) received approval from the European Commission for its acquisition of the company in a $39 billion deal. The new unit is named ‘Alexion, AstraZeneca Rare Disease’ and is based in Boston, U.S.

Tudor Investment Corp holds 907,855 shares in Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), worth over $166.7 million. The company represents 3.15% of the fund’s portfolio. In the second quarter of 2021, Tudor Investment Corp increased its activity in Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) by 73%. The company’s acquisition by AstraZeneca PLC (NASDAQ: AZN) marks its entry into medicines for rare diseases, especially conditions involving immune systems. In May, Oppenheimer upgraded Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) to ‘Outperform’, with a $250 price target.

As of Q2 2021, 69 hedge funds have positions in Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), worth over $10 billion.

You can also take a look at 10 Best Dividend Aristocrats to Buy According to Hedge Funds and 10 Best Dividend Stocks to Buy According to John Khoury’s Long Pond Capital

Follow Insider Monkey on Twitter